Galenica 2008 Revenue Up 6.9% At CHF2.7 Billion, Confirms 2008 Outlook - EasyBourse.com PDF Print

Vifor Pharma will push ahead with its strategy for more market focus and will expand its position as leader in the therapy areas of anaemia and nephrology. ...

read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.